arrow
Back
C

Chrysavgi Kosti

athens medical school

5H-index
16Paper Count
121Citation Count
Published Papers 10
Publication Date
Airway Resistotypes and Clinical Outcomes in Bronchiectasis
err2024-07-01
err11
errOAAI
errMac Aogain, Micheal; Ivan, Fransiskus Xaverius; Jaggi, Tavleen Kaur; Richardson, Hollian; Shoemark, Amelia; Narayana, Jayanth Kumar; Dicker, Alison J.; Koh, Mariko Siyue; Lee, Ken Cheah Hooi; How, Ong Thun; Poh, Mau Ern; Chin, Ka Kiat; Hou, Albert Lim Yick; Hon, Puah Ser; Low, Teck Boon; Abisheganaden, John Arputhan; Dimakou, Katerina; Digalaki, Antonia; Kosti, Chrysavgi; Gkousiou, Anna; Hansbro, Philip M.; Blasi, Francesco; Aliberti, Stefano; Chalmers, James D.; Chotirmall, Sanjay H.
errShare
errSave
Comparison of effectiveness between baricitinib and tocilizumab in severe COVID-19. A retrospective study.
err2023-10-27
err0
PREAI
errTomos, Ioannis; Grigoropoulos, Ioannis; Kosti, Chrysavgi; Chrysikos, Serafeim; Digalaki, Antonia; Thomas, Konstantinos; Hillas, Georgios; Boumpas, Dimitrios; Antoniadou, Anastasia; Kavatha, Dimitra; Dimakou, Katerina
errShare
errSave
Efficacy of inhaled tobramycin in adult patients with bronchiectasis and P. aeruginosa in sputum: a prospective observational study
err2023-10-27
err0
PREAI
errKosti, Chrysavgi; Digalaki, Antonia; Matthaiou, Andreas; Koukidou, Sofia; Zervou, Emmanouela; Sakellaropoulou, Aikaterini-Ioanna; Roussis, Ioannis; Chrysikos, Serafeim; Hillas, Georgios; Dimakou, Katerina
errShare
errSave
Clinical characteristics and imaging of adult PCD patients: a single-center experience
err2022-12-01
err0
PREAI
errKosti, C.; Tzilas, V.; Digalaki, A.; Koukidou, S.; Tomos, I.; Hillas, G.; Chrysikos, S.; Zervou, E.; Dimakou, K.; Digalaki, A.
errShare
errSave
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
err2022-06-20
err3
errOAAI
errPagkratis, Konstantinos; Chrysikos, Serafeim; Antonakis, Emmanouil; Pandi, Aggeliki; Kosti, Chrysavgi Nikolaou; Markatis, Eleftherios; Hillas, Georgios; Digalaki, Antonia; Koukidou, Sofia; Chaini, Eleftheria; Afthinos, Andreas; Dimakou, Katerina; Papanikolaou, Ilias C.
errShare
errSave
CSF1/CSF1R signaling mediates malignant pleural effusion formation
err2022-03-22
err14
errOAAI
errKosti, Chrysavgi N.; Vaitsi, Photene C.; Pappas, Apostolos G.; Iliopoulou, Marianthi P.; Psarra, Katherina K.; Magkouta, Sophia F.; Kalomenidis, Ioannis T.
errShare
errSave
MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage
err2020-06-18
err11
errOAAI
errMagkouta, Sophia F.; Pappas, Apostolos G.; Vaitsi, Photene C.; Agioutantis, Panagiotis C.; Pateras, Ioannis S.; Moschos, Charalampos A.; Iliopoulou, Marianthi P.; Kosti, Chrysavgi N.; Loutrari, Heleni V.; Gorgoulis, Vassilis G.; Kalomenidis, Ioannis T.
errShare
errSave
CSF1R INHIBITION RETARDS MESOTHELIOMA PROGRESSION AND AMPLIFIES CHECKPOINT THERAPY
errCHEST
IF8.6
err2019-06-01
err0
PREAI
errMagkouta, S.; Vaitsi, P.; Pappas, A.; Moschos, C.; Iliopoulou, M.; Kosti, C.; Psarra, K.; Kalomenidis, I.
errShare
errSave
Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion
err2018-11-19
err0
PREAI
errMagkouta, Sophia; Kosti, Chrysavgi; Vaitsi, Photene; Pappas, Apostolos; Moschos, Charalampos; Iliopoulou, Marianthi; Psarra, Katherina; Kalomenidis, Ioannis
errShare
errSave
MTH-1 inhibition retards mesothelioma progression
err2017-12-06
err0
PREAI
errMagkouta, Sophia; Pappas, Apostolos; Kosti, Chrysavgi; Iliopoulou, Marianthi; Psarra, Katherina; Kalomenidis, Ioannis
errShare
errSave